Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence

被引:347
作者
Cerny, A
Chisari, FV
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] Univ Bern, Inselspital, Dept Internal Med, CH-3010 Bern, Switzerland
关键词
D O I
10.1002/hep.510300312
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The immune response to viral antigens is thought to be responsible for viral clearance and disease pathogenesis during hepatitis C virus (HCV) infection. In chronically infected patients, the T-cell response to the HCV is polyclonal and multispecific, although it is not as strong as the response in acutely infected patients who display a more vigorous T-cell response. Importantly, viral clearance in acutely infected patients is associated with a strong CD4(+) helper T-cell response. Thus, the dominant cause of viral persistence during HCV infection may be the development of a weak antiviral immune response to the viral antigens, with corresponding inability to eradicate infected cells. Alternatively, if clearance of HCV from the liver results from the antiviral effect of T-cell-derived cytokines, as has been demonstrated recently for the hepatitis B virus, chronic HCV infection could occur if HCV is not sensitive to such cytokines or if insufficient quantities of cytokines are produced, Liver cell damage may extend from virally infected to uninfected cells via soluble cytotoxic mediators and recruitment and activation of inflammatory cells forming the necroinflammatory response. Additional factors that could contribute to viral persistence are viral inhibition of antigen processing or presentation, modulation of the response to cytotoxic mediators, immunological tolerance to HCV antigens, mutational inactivation of cytotoxic T lymphocyte (CTL) epitopes, mutational conversion of CTL epitopes into CTL antagonists, and infection of immunologically privileged tissues. Analysis of the basis for viral persistence is hampered because the necessary cell culture system and animal model to study this question do not yet exist.
引用
收藏
页码:595 / 601
页数:7
相关论文
共 100 条
  • [71] Hepatic fas antigen expression before and after interferon therapy in patients with chronic hepatitis C
    Okazaki, M
    Hino, K
    Fujii, K
    Kobayashi, N
    Okita, K
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) : 2453 - 2458
  • [72] How viruses escape from cytotoxic T lymphocytes: Molecular parameters and players
    Oldstone, MBA
    [J]. VIROLOGY, 1997, 234 (02) : 179 - 185
  • [73] Binding of hepatitis C virus to CD81
    Pileri, P
    Uematsu, Y
    Campagnoli, S
    Galli, G
    Falugi, F
    Petracca, R
    Weiner, AJ
    Houghton, M
    Rosa, D
    Grandi, G
    Abrignani, S
    [J]. SCIENCE, 1998, 282 (5390) : 938 - 941
  • [74] Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: Correlation with response to interferon therapy
    Polyak, SJ
    Faulkner, G
    Carithers, RL
    Corey, L
    Gretch, DR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (05) : 1101 - 1107
  • [75] Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
    Price, DA
    Goulder, PJR
    Klenerman, P
    Sewell, AK
    Easterbrook, PJ
    Troop, M
    Bangham, CRM
    Phillips, RE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 1890 - 1895
  • [76] Inhibition of tumor necrosis factor (TNF-α)-mediated apoptosis by hepatitis C virus core protein
    Ray, RB
    Meyer, K
    Steele, R
    Shrivastava, A
    Aggarwal, BB
    Ray, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) : 2256 - 2259
  • [77] Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
    Rehermann, B
    Chang, KM
    McHutchison, J
    Kokka, F
    Houghton, M
    Rice, CM
    Chisari, FV
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (10) : 7092 - 7102
  • [78] Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection
    Rehermann, B
    Chang, KM
    McHutchison, JG
    Kokka, R
    Houghton, M
    Chisari, FV
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (06) : 1432 - 1440
  • [79] A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
    Rosa, D
    Campagnoli, S
    Moretto, C
    Guenzi, E
    Cousens, L
    Chin, M
    Dong, C
    Weiner, AJ
    Lau, JYN
    Choo, QL
    Chien, D
    Pileri, P
    Houghton, M
    Abrignani, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) : 1759 - 1763
  • [80] Jaundice at onset signifies a good prognosis in anti-D-associated HCV infection
    Sachithanandan, S
    Fielding, JF
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (01) : 77 - 79